Tissue factor is induced by interleukin-33 in human endothelial cells: A new link between coagulation and inflammation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Stojkovic, Stefan ^a,b   Kaun, Christoph ^a   Basilio, Jose ^a   Rauscher, Sabine ^a   Hell, Lena ^a   Krychtiuk, Konstantin A ^a   Bonstingl, Cornelia ^c   De Martin, Rainer ^a   Gröger, Marion ^a   Ay, Cihan ^a   Holnthoner, Wolfgang ^c,d   Eppel, Wolfgang ^e   Neumayer, Christoph ^a   Huk, Ihor ^a   Huber, Kurt ^f   Demyanets, Svitlana ^a   Wojta, Johann ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

^c AUVA Soziale Unfallversicherung   (Austria)

^d AUSTRIAN CLUSTER FOR TISSUE REGENERATION   (Austria)

^e UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^f WILHELMINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IL33 PROTEIN, HUMAN; INTERLEUKIN 33; MESSENGER RNA; THROMBOPLASTIN;

BIOSYNTHESIS; BLOOD CLOTTING; CELL CULTURE; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-33; RNA, MESSENGER; THROMBOPLASTIN;

EID: 84965124582     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25171     Document Type: Article

References (51)

1. De Caterina, R. et al. General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Thromb Haemost 109, 569-579 (2013).
2. Wilcox, J. N., Smith, K. M., Schwartz, S. M. & Gordon, D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86, 2839-2843 (1989).
3. Annex, B. H. et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 91, 619-622 (1995).
4. Mallat, Z. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843 (2000).
5. Breitenstein, A., Tanner, F. C. & Luscher, T. F. Tissue factor and cardiovascular disease: quo vadis? Circ J 74, 3-12 (2010).
6. Badimon, L. & Vilahur, G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 276, 618-632 (2014).
7. Demetz, G. et al. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. Atherosclerosis 212, 466-471 (2010).
8. Bode, M. & Mackman, N. Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player. Vascul Pharmacol 62, 57-62 (2014).
9. Hansen, J. B. et al. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro. Thromb Haemost 83, 937-943 (2000).
10. Lupu, C., Lupu, F., Dennehy, U., Kakkar, V. V. & Scully, M. F. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 15, 2055-2062 (1995).
11. Winckers, K., ten Cate, H. & Hackeng, T. M. The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis. Blood Rev 27, 119-132 (2013).
12. Badimon, J. J. et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99, 1780-1787 (1999).
13. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490 (2005).
14. Liew, F. Y., Pitman, N. I. & McInnes, I. B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10, 103-110 (2010).
15. Kakkar, R., Hei, H., Dobner, S. & Lee, R. T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287, 6941-6948 (2012).
16. Miller, A. M. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8, 22 (2011).
17. Rose, W. A., Okragly, A. J., Patel, C. N. & Benschop, R. J. IL-33 released by alum is responsible for early cytokine production and has adjuvant properties. Sci Rep 5, 13146; doi: 13110.11038/srep13146 (2015).
18. Demyanets, S. et al. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 31, 2080-2089 (2011).
19. Aoki, S. et al. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells. Mol Cell Biochem 335, 75-81 (2010).
20. Choi, Y. S. et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 114, 3117-3126 (2009).
21. Stojkovic, S. et al. Interleukin-33 induces urokinase in human endothelial cells-possible impact on angiogenesis. J Thromb Haemost 12, 948-957 (2014).
22. Demyanets, S. et al. Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome. PLoS One 9, e95055 (2014).
23. Dhillon, O. S. et al. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers? Int J Cardiol 167, 2182-2188 (2013).
24. Demyanets, S. et al. An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis. Cytokine 67, 65-70 (2014).
25. Zipperle, J. et al. A novel coagulation assay incorporating adherent endothelial cells in thromboelastometry. Thromb Haemost 109, 869-877 (2013).
26. Krychtiuk, K. A., Kastl, S. P., Speidl, W. S. & Wojta, J. Inflammation and coagulation in atherosclerosis. Hamostaseologie 33, 269-282 (2013).
27. Kastl, S. P. et al. Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation. Blood 114, 2812-2818 (2009).
28. Jackson, S. P. Arterial thrombosis--insidious, unpredictable and deadly. Nat Med 17, 1423-1436 (2011).
29. Guzik, T. J. & Dulak, J. Vessel wall-where coagulation meets cell biology and immunology. Thromb Haemost 108, 416-418 (2012).
30. Steffel, J., Luscher, T. F. & Tanner, F. C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113, 722-731 (2006).
31. Steffel, J. et al. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 111, 1685-1689 (2005).
32. Napoleone, E., Di Santo, A. & Lorenzet, R. Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 89, 541-549 (1997).
33. Owens, A. P., 3rd & Mackman, N. Microparticles in hemostasis and thrombosis. Circ Res 108, 1284-1297 (2011).
34. Collier, M. E. & Ettelaie, C. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation. Arterioscler Thromb Vasc Biol 30, 1810-1817 (2010).
35. Demyanets, S. et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol 60, 16-26 (2013).
36. Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J Exp Med 205, 339-346 (2008).
37. Loewe, R. et al. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. J Immunol 168, 4781-4787 (2002).
38. Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S. & Gimbrone, M. A., Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160, 618-623 (1984).
39. Bevilacqua, M. P. et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83, 4533-4537 (1986).
40. Kasthuri, R. S., Glover, S. L., Boles, J. & Mackman, N. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays. Semin Thromb Hemost 36, 764-771 (2010).
41. Shen, J. et al. IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study. Semin Arthritis Rheum 45, 18-27 (2015).
42. McLaren, J. E. et al. IL-33 reduces macrophage foam cell formation. J Immunol 185, 1222-1229 (2010).
43. Martin, P. et al. Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling. Immun Inflamm Dis 3, 239-246 (2015).
44. Pollheimer, J. et al. Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells. Arterioscler Thromb Vasc Biol 33, e47-55 (2013).
45. Ali, S. et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 187, 1609-1616 (2011).
46. Pichery, M. et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188, 3488-3495 (2012).
47. Sundnes, O. et al. Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences. J Invest Dermatol 135, 1771-1780 (2015).
48. Wojta, J., Zoellner, H., Gallicchio, M., Hamilton, J. A. & McGrath, K. Gamma-interferon counteracts interleukin-1 alpha stimulated expression of urokinase-type plasminogen activator in human endothelial cells in vitro. Biochem Biophys Res Commun 188, 463-469 (1992).
49. Khorana, A. A. et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6, 1983-1985 (2008).
50. de Martin, R., Raidl, M., Hofer, E. & Binder, B. R. Adenovirus-mediated expression of green fluorescent protein. Gene Ther 4, 493-495 (1997).
51. Eilenberg, W. et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg in press (2016).